Associated Papers
Survivin (BIRC5) Gene Polymorphism (rs9904341) Is Associated with Cancer Risk: A Meta-Analysis.
Malviya N et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2025
The analysis of Survivin promoter (-31G/C) gene variation in oral squamous cell carcinoma risk and prognosis.
Cacına C et al.
Journal of Stomatology, Oral and Maxillofacial Surgery, 2023
The survivin molecule as a double-edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer.
Rafatmanesh A et al.
Journal of Cellular Physiology, 2020
The effect of polymorphisms in the promoter of the BIRC5 gene on the risk of oesophageal squamous cell carcinoma and patient's outcomes.
Wang N et al.
Mutagenesis, 2019
Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer
Mehdi RF et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2019
Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
Moazeni-Roodi A et al.
International Journal of Clinical Oncology, 2019
Investigation of Survivin Gene Polymorphism and Serum Survivin Levels in Patients with Brain Tumors.
Kafadar D et al.
Anticancer Research, 2018
The -31 G/C promoter gene polymorphism of surviving in Turkish colorectal cancers patients
Budak M et al.
The Ceylon Medical Journal, 2018
Genotypic distribution of single nucleotide polymorphisms in oral cancer: global scene.
Multani S et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2016
Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients.
Jenko B et al.
Pharmacogenomics, 2016
Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.
Liu TC et al.
International Journal of Medical Sciences, 2016
Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
Rapti E et al.
Genetic Testing and Molecular Biomarkers, 2015
Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
Yamak N et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2014
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY et al.
Lung Cancer (amsterdam, Netherlands), 2013
Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
Liu Y et al.
Plos One, 2013
Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
Hsieh YS et al.
Annals of Surgical Oncology, 2012
Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
Wang X et al.
European Journal of Human Genetics : Ejhg, 2012
Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK et al.
Molecular Biology Reports, 2012
Survivin SNP-carcinogen interactions in oral cancer.
Weng CJ et al.
Journal of Dental Research, 2012
Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study.
Li Y et al.
Bmc Medical Genetics, 2012
Association of survivin gene polymorphism with endometrial cancer.
Zahedi P et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2012
Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C et al.
Plos One, 2012
Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
Kawata N et al.
International Journal of Cancer, 2011
A functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population.
Zhang Y et al.
Bmc Medicine, 2011
Survivin promoter -31G/C polymorphism in oral cancer cell lines.
de Maria S et al.
Oncology Letters, 2011
Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.
Ma F et al.
Plos One, 2011
The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism.
Boidot R et al.
Oncogene, 2010
The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.
Yang L et al.
Digestive Diseases and Sciences, 2009
Gene polymorphisms, apoptotic capacity and cancer risk.
Imyanitov EN
Human Genetics, 2009
Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
Wang YH et al.
Urology, 2009
Polymorphisms in the survivin gene and the risk of lung cancer.
Jang JS et al.
Lung Cancer (amsterdam, Netherlands), 2008
Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population.
Bogdanovic L et al.
Journal of B.u.on. : Official Journal of the Balkan Union of Oncology, 0